Organism 57278 - Lissoclinum bistratum (DIDEMNIDAE)

Organisms in NAP refer to specimens, they are not "taxonomical" organisms and they can in some cases even be mixtures of organisms. Empty organisms are used as placeholders as the original dataset entry system used organism as the central part.
Search for all experiments on this taxon

Organism Details

PropertyValue
Taxon30153
FamilyDIDEMNIDAE
GenusLISSOCLINUM
SpeciesBISTRATUM
Species authority
Subspecies
Subspecies authority
Comment
CitationCOTELLE,P: FOSTER,MP: IRELAND,CM: DEBITUS,C:. (1994). BISTRAMIDES A,B,C,D, AND K: A NEW CLASS OF BIOACTIVE CYCLIC POLYETHERS FROM LISSOCLINUM BISTRATUM.. 57(10)
Geographical areaOCEANIA
CountryPACIFIC(NEW CALEDONIA)

Experiments

Filters
Worktypes (12)
35
33
5
5
5
5
5
5
4
3
1
1
No match
Pharmacology (4)
30
5
3
5
No match
Compounds (5)
9
9
9
8
8
No match
43 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
167960
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE B
167961
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE B
167962
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE B
167963
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE B
167964
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE B
167965
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE B
167966
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE B
167967
PHARMACOLOGY OF COMPOUND - IN VITRO
CELL CYCLE CYTOTOXICITY(G1 PHASE)
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE B
167968
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE C
167969
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE C
167970
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE C
167971
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE C
167972
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE C
167973
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE C
167974
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE C
167975
PHARMACOLOGY OF COMPOUND - IN VITRO
CELL CYCLE CYTOTOXICITY(G1 PHASE)
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE C
167976
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE D
167977
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE D
167978
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE D
167979
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE D
167980
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE D
167981
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE D
167982
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE D
167983
PHARMACOLOGY OF COMPOUND - IN VITRO
CELL CYCLE CYTOTOXICITY(G1 PHASE)
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE D
167984
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE D
167985
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE K
167986
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE K
167987
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE K
167988
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE K
167989
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE K
167990
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE K
167991
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE K
167992
PHARMACOLOGY OF COMPOUND - IN VITRO
CELL CYCLE CYTOTOXICITY(G1 PHASE)
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE K
167993
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE K
167994
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE A
167995
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE A
167996
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE A
167997
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE A
167998
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE A
167999
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE A
168000
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE A
168001
PHARMACOLOGY OF COMPOUND - IN VITRO
CELL CYCLE CYTOTOXICITY(G1 PHASE)
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE A
168002
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE A
Show SPARQL Queries (1)